1. Home
  2. CNSP vs STKH Comparison

CNSP vs STKH Comparison

Compare CNSP & STKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$6.04

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Logo Steakholder Foods Ltd.

STKH

Steakholder Foods Ltd.

HOLD

Current Price

$2.50

Market Cap

3.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNSP
STKH
Founded
2017
2018
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
3.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
CNSP
STKH
Price
$6.04
$2.50
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
73.0K
122.4K
Earning Date
11-17-2025
04-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.93
$2.00
52 Week High
$114.00
$68.00

Technical Indicators

Market Signals
Indicator
CNSP
STKH
Relative Strength Index (RSI) 45.58 51.36
Support Level $5.75 $2.00
Resistance Level $7.51 $2.48
Average True Range (ATR) 0.72 0.19
MACD 0.09 0.02
Stochastic Oscillator 22.58 80.95

Price Performance

Historical Comparison
CNSP
STKH

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

Share on Social Networks: